| scholarly article | Q13442814 |
| P50 | author | Mattias Carlstrom | Q64605731 |
| Valdir A Braga | Q86592416 | ||
| P2093 | author name string | Jon O Lundberg | |
| Luciano L Paulo | |||
| Marcelo F Montenegro | |||
| Maria C R Brandão | |||
| Petrônio F Athayde-Filho | |||
| Virginia S Lemos | |||
| Alynne Carvalho-Galvão | |||
| Josiane Campos Cruz | |||
| Sarah McCann Haworth | |||
| Thiago F Diniz | |||
| Zhengbing Zhuge | |||
| P2860 | cites work | Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 |
| The identification of nitric oxide as endothelium-derived relaxing factor | Q26823143 | ||
| Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review) | Q26823520 | ||
| Mechanisms of nitrite bioactivation | Q28384653 | ||
| Synthesis and characterization of a novel organic nitrate NDHP: Role of xanthine oxidoreductase-mediated nitric oxide formation | Q33761296 | ||
| Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview | Q34489991 | ||
| Redox and nitric oxide-mediated regulation of sensory neuron ion channel function | Q35068102 | ||
| Inwardly rectifying potassium channels in the regulation of vascular tone | Q35109027 | ||
| Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway | Q35206668 | ||
| Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. | Q35564144 | ||
| Cross-talk Between Nitrate-Nitrite-NO and NO Synthase Pathways in Control of Vascular NO Homeostasis | Q35910804 | ||
| Vascular inflammatory cells in hypertension | Q35939300 | ||
| The new nitric oxide donor cyclohexane nitrate induces vasorelaxation, hypotension, and antihypertensive effects via NO/cGMP/PKG pathway. | Q36008721 | ||
| The role of nitric oxide in cardiovascular diseases | Q36049491 | ||
| Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly. | Q36077331 | ||
| Methods to detect nitric oxide and its metabolites in biological samples | Q36092089 | ||
| Nitric oxide mimetic molecules as therapeutic agents in Alzheimer's disease | Q36172687 | ||
| Explaining the phenomenon of nitrate tolerance | Q36272905 | ||
| Sympathetic overactivity occurs before hypertension in the two-kidney, one-clip model. | Q36480001 | ||
| Nitric oxide signaling in the microcirculation | Q36717720 | ||
| Heme proteins mediate the conversion of nitrite to nitric oxide in the vascular wall | Q36844531 | ||
| Nitric oxide generation by the organic nitrate NDBP attenuates oxidative stress and angiotensin II-mediated hypertension | Q37034771 | ||
| Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? | Q37230725 | ||
| Long-term use of short- and long-acting nitrates in stable angina pectoris | Q37481637 | ||
| TREK-1 K(+) channels in the cardiovascular system: their significance and potential as a therapeutic target | Q37800140 | ||
| Pain and analgesia: The dual effect of nitric oxide in the nociceptive system | Q37896960 | ||
| Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds | Q37900879 | ||
| A comparison of organic and inorganic nitrates/nitrites | Q38001534 | ||
| Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis? | Q38113301 | ||
| Nitric oxide modulators: an emerging class of medicinal agents | Q38116861 | ||
| The chemistry and biology of soluble guanylate cyclase stimulators and activators | Q38130465 | ||
| Epigenetics and arterial hypertension: the challenge of emerging evidence. | Q38230822 | ||
| Organic nitrates: past, present and future. | Q38254229 | ||
| Strategies to increase nitric oxide signalling in cardiovascular disease | Q38565004 | ||
| KATP channels in vascular smooth muscle | Q40630784 | ||
| Renal denervation attenuates hypertension and renal dysfunction in a model of cardiovascular and renal disease, which is associated with reduced NADPH and xanthine oxidase activity. | Q41084517 | ||
| Time-course effects of aerobic exercise training on cardiovascular and renal parameters in 2K1C renovascular hypertensive rats. | Q42284824 | ||
| NADPH oxidase in the renal microvasculature is a primary target for blood pressure-lowering effects by inorganic nitrate and nitrite. | Q42467124 | ||
| Vitamin C prevents DNA damage induced by renovascular hypertension in multiple organs of Wistar rats | Q43201214 | ||
| Performance of diamino fluorophores for the localization of sources and targets of nitric oxide. | Q45209856 | ||
| Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis. | Q46473852 | ||
| Dietary nitrate improves age-related hypertension and metabolic abnormalities in rats via modulation of angiotensin II receptor signaling and inhibition of superoxide generation | Q46473945 | ||
| Mechanisms underlying the hypotensive and vasodilator effects of Ru(terpy)(bdq)NO](3+), a nitric oxide donor, differ between normotensive and spontaneously hypertensive rats. | Q46844421 | ||
| Sexual dysfunction in arterial hypertension women: The role of depression and anxiety | Q47704720 | ||
| Gallic acid isolated from Spirogyra sp. improves cardiovascular disease through a vasorelaxant and antihypertensive effect. | Q50438598 | ||
| Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. | Q50773580 | ||
| The use of nitric oxide donors in pharmacological studies. | Q53947007 | ||
| In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide | Q71745465 | ||
| Potassium channels and regulation of the microcirculation | Q77466514 | ||
| Nitric oxide (NO) detection by DAF fluorescence and chemiluminescence: a comparison using abiotic and biotic NO sources | Q80070853 | ||
| Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases | Q82954031 | ||
| Cardiorespiratory effects induced by 2-nitrate-1,3-dibuthoxypropan are reduced by nitric oxide scavenger in rats | Q87086477 | ||
| Managed by the markets | Q111690464 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 182-191 | |
| P577 | publication date | 2017-12-11 | |
| P1433 | published in | Redox Biology | Q27724751 |
| P1476 | title | The novel organic mononitrate NDHP attenuates hypertension and endothelial dysfunction in hypertensive rats | |
| P478 | volume | 15 |
| Q55260529 | Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway. | cites work | P2860 |
Search more.